Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance
恶性疟原虫反应和耐药性的化学基因组学分析
基本信息
- 批准号:10449354
- 负责人:
- 金额:$ 69.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-10 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AfricaAnabolismAnti-malarial drug resistanceAntimalarialsArtemisininsAsiaBloodBlood CirculationCRISPR/Cas technologyCessation of lifeClinicalCombined Modality TherapyComplexCoupledDNA Sequence AlterationDevelopmentDigestionDiseaseDrug TargetingDrug usageFalciparum MalariaFeverFoodGene Expression ProfileGenesGenetic CrossesGenetic ScreeningGenomeGenomic LibraryGenotypeHeat shock proteinsHeat-Shock ResponseHemeHemoglobinHumanLibrariesLinkMalariaMeasuresMediatingMetabolicModelingMutagenesisMutationOntologyOxidative StressParasitesPathway interactionsPharmaceutical PreparationsPharmacotherapyPhenotypePlasmodiumPlasmodium falciparumPlasmodium vivaxProcessProteinsReactive Oxygen SpeciesResearchResistanceToxic effectVacuoleartesunateasexualbiological adaptation to stresscomparativecostdocosahexaenoylascorbic aciddrug discoveryfitnessgene discoverygenome editingglobal healthinhibitorisoprenoidmulticatalytic endopeptidase complexmutantresponsetooltranscriptome sequencingwhole genome
项目摘要
Project Summary/Abstract
Malaria is a leading cause of human death and illness, causing over 200 million cases of clinical
malaria and 400,000 deaths each year. Traditional measures to control and cure malaria are
threatened by emergence of artemisinin resistance (ART-R). Research into ART-R has focused
mostly on mechanisms allowing parasite to tolerate the oxidative stress and protein damage
resulting from ART’s mechanism of action. However, recent discoveries indicate that resistance-
associated mutations in the K13 slows cytostome function to diminish the available hemoglobin in
the food vacuole. Our preliminary results revealed that the parasite’s sensitivity and tolerance to
ART significantly overlaps with innate stress response pathways that enable P. falciparum survival
of malaria fever. Our experimental approach is to elucidate drug-gene associations and decipher
mechanisms of action and resistance to ART and other antimalarial drugs, using forward genetic
screens of P. falciparum mutants created by random piggyBac mutagenesis. This approach has
determined that genetic mutations in the major parasite processes critical for P. falciparum malarial
fever survival response significantly correlate with altered sensitivity to ART (DHA, AS), indicating
the parasite hijacked the heat-shock stress response pathways to cope with ART toxicity. We will
use small libraries of piggyBac clones and GO-focused libraries for iterative screens of different
phenotypes to functionally annotate interacting partners, pathways, and regulatory processes
linked to ART mechanism of action and resistance. We will use genome-level screens to identify
factors linked to ART mechanism of action. We will extend our analysis to P. knowlesi to
characterize the conserved high-value antimalarial drug targets by adapting and applying
chemogenomic profiling analysis to this vivax-like malaria parasite.
项目总结/摘要
疟疾是人类死亡和疾病的主要原因,造成超过2亿例临床病例,
每年有40万人死于疟疾。控制和治疗疟疾的传统措施是
受到青蒿素耐药性(ART-R)出现的威胁。对ART-R的研究集中在
主要研究寄生虫耐受氧化应激和蛋白质损伤的机制
这是由于ART的作用机制。然而,最近的发现表明,耐药性-
K13的相关突变减缓了细胞口功能,从而减少了细胞中可用的血红蛋白。
食物泡我们的初步结果表明,寄生虫的敏感性和耐受性
ART与使恶性疟原虫存活的先天应激反应途径显著重叠
疟疾发烧。我们的实验方法是阐明药物基因协会和破译
使用正向遗传学方法研究抗逆转录病毒疗法和其他抗疟药物的作用机制和耐药性
筛选通过随机piggyBac诱变产生的恶性疟原虫突变体。这种方法有
确定主要寄生虫过程中的基因突变对恶性疟原虫疟疾至关重要,
发热存活反应与ART敏感性改变(DHA,AS)显著相关,表明
寄生虫劫持了热休克应激反应途径来科普ART毒性。我们将
使用piggyBac克隆的小文库和GO聚焦文库进行不同的重复筛选,
表型功能注释相互作用的伙伴,途径和监管过程
与抗逆转录病毒疗法的作用机制和耐药性有关。我们将使用基因组水平的筛选来识别
与ART作用机制相关的因素。我们将把我们的分析扩展到P. knowlesi,
通过调整和应用,
化学基因组分析,这种间日疟原虫样疟疾寄生虫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John H Adams其他文献
John H Adams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John H Adams', 18)}}的其他基金
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
加速发现有效的间日疟原虫多价多阶段疫苗
- 批准号:
10307530 - 财政年份:2020
- 资助金额:
$ 69.48万 - 项目类别:
Evaluation of ivermectin as an antimalarial therapy against P. falciparum liver stage
伊维菌素抗疟治疗恶性疟原虫肝期的评价
- 批准号:
10001705 - 财政年份:2020
- 资助金额:
$ 69.48万 - 项目类别:
Plasmodium ovale hypnozoite development and relapse: a coordinated in vivo in vitro study
卵形疟原虫休眠子的发育和复发:体内体外协调研究
- 批准号:
10304203 - 财政年份:2020
- 资助金额:
$ 69.48万 - 项目类别:
Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine
加速发现有效的间日疟原虫多价多阶段疫苗
- 批准号:
10526422 - 财政年份:2020
- 资助金额:
$ 69.48万 - 项目类别:
Evaluation of ivermectin as an antimalarial therapy against P. falciparum liver stage
伊维菌素抗疟治疗恶性疟原虫肝期的评价
- 批准号:
10170295 - 财政年份:2020
- 资助金额:
$ 69.48万 - 项目类别:
Discovering the essential genome of Plasmodium falciparum
发现恶性疟原虫的基本基因组
- 批准号:
10164710 - 财政年份:2018
- 资助金额:
$ 69.48万 - 项目类别:
Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance
恶性疟原虫反应和耐药性的化学基因组学分析
- 批准号:
10317747 - 财政年份:2015
- 资助金额:
$ 69.48万 - 项目类别:
Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance
恶性疟原虫药物反应和耐药性的化学基因组学分析
- 批准号:
8864956 - 财政年份:2015
- 资助金额:
$ 69.48万 - 项目类别:
Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance
恶性疟原虫药物反应和耐药性的化学基因组学分析
- 批准号:
9206137 - 财政年份:2015
- 资助金额:
$ 69.48万 - 项目类别:
Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance
恶性疟原虫药物反应和耐药性的化学基因组分析
- 批准号:
9012006 - 财政年份:2015
- 资助金额:
$ 69.48万 - 项目类别:
相似海外基金
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10590611 - 财政年份:2022
- 资助金额:
$ 69.48万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
- 批准号:
10706006 - 财政年份:2022
- 资助金额:
$ 69.48万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10368975 - 财政年份:2021
- 资助金额:
$ 69.48万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10365254 - 财政年份:2021
- 资助金额:
$ 69.48万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10202896 - 财政年份:2021
- 资助金额:
$ 69.48万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10531570 - 财政年份:2021
- 资助金额:
$ 69.48万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10541847 - 财政年份:2019
- 资助金额:
$ 69.48万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10319573 - 财政年份:2019
- 资助金额:
$ 69.48万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10062790 - 财政年份:2019
- 资助金额:
$ 69.48万 - 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
- 批准号:
DE170100628 - 财政年份:2017
- 资助金额:
$ 69.48万 - 项目类别:
Discovery Early Career Researcher Award














{{item.name}}会员




